PRA Health Sciences’ Early Development Services (EDS) group has a long-standing record of early clinical development work in various neuroscience and pain indication. In the past decade, PRA EDS in the Netherlands has gained extensive experience in neuroactive drug development through 160+ Phase I and Phase II clinical studies. PRA’s US clinical research centers offer addition expertise in neuroscience and pain early phase trials.
First-in-Human Drug Evaluation at PRA Health Sciences & The Revised EMA Guideline on Early Clinical Trials
In July 2017, the European Medicines Agency (EMA) published its revised guidance on first-in-human (FIH) and early clinical trials. The revision…
Onsite Manufacturing Early Clinical Development
Early drug development requires adherence to Good Manufacturing Practices (GMP) guidelines when manufacturing investigational medicinal products…
Salt Lake City Research Unit
Video highlighting Salt Lake City Resarch Unit, and its capabilities